Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were overweight or had obesity.

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...

Health insurance will grow more expensive in many corners of the market in 2026, and coverage may shrink. That could leave ...

Zepbound is a prescription drug used for weight management and obstructive sleep apnea. While depression was not reported in studies of Zepbound, it's still something to watch out for while using ...